Piramal Pharma acquires controlling stake in Yapan Bio
after close1 source ↓written by the desknot a recommendation
- in Yapan Bio
- 40.67% stake
- Private Limited
- ₹76 crore
- its ownership
- 74%
Piramal Pharma Ltd. has completed the acquisition of a 40.67% stake in Yapan Bio Private Limited for ₹76 crore, increasing its ownership to 74%. This acquisition transforms Yapan Bio into a subsidiary, enhancing Piramal's capabilities in large molecule CDMO services for vaccines and biologics. This strategic move may strengthen Piramal's position in the growing biopharmaceutical sector.
Not investment advice. For informational purposes only.